[English] 日本語
Yorodumi- PDB-7uso: Crystal Structure of Caspase-3 with Peptide Inhibitor AcITVKD-CHO -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 7uso | ||||||
|---|---|---|---|---|---|---|---|
| Title | Crystal Structure of Caspase-3 with Peptide Inhibitor AcITVKD-CHO | ||||||
Components |
| ||||||
Keywords | HYDROLASE/HYDROLASE INHIBITOR / Complex / Peptide Inhibitor / Covalent inhibitor / APOPTOSIS / HYDROLASE-HYDROLASE INHIBITOR complex | ||||||
| Function / homology | Function and homology informationcaspase-3 / phospholipase A2 activator activity / Stimulation of the cell death response by PAK-2p34 / anterior neural tube closure / intrinsic apoptotic signaling pathway in response to osmotic stress / leukocyte apoptotic process / positive regulation of pyroptotic inflammatory response / glial cell apoptotic process / NADE modulates death signalling / luteolysis ...caspase-3 / phospholipase A2 activator activity / Stimulation of the cell death response by PAK-2p34 / anterior neural tube closure / intrinsic apoptotic signaling pathway in response to osmotic stress / leukocyte apoptotic process / positive regulation of pyroptotic inflammatory response / glial cell apoptotic process / NADE modulates death signalling / luteolysis / response to cobalt ion / cellular response to staurosporine / cyclin-dependent protein serine/threonine kinase inhibitor activity / death-inducing signaling complex / Apoptosis induced DNA fragmentation / Apoptotic cleavage of cell adhesion proteins / Caspase activation via Dependence Receptors in the absence of ligand / SMAC, XIAP-regulated apoptotic response / Activation of caspases through apoptosome-mediated cleavage / Signaling by Hippo / SMAC (DIABLO) binds to IAPs / SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes / axonal fasciculation / regulation of synaptic vesicle cycle / death receptor binding / fibroblast apoptotic process / epithelial cell apoptotic process / platelet formation / Other interleukin signaling / response to anesthetic / execution phase of apoptosis / negative regulation of cytokine production / positive regulation of amyloid-beta formation / Apoptotic cleavage of cellular proteins / negative regulation of B cell proliferation / pyroptotic inflammatory response / neurotrophin TRK receptor signaling pathway / negative regulation of activated T cell proliferation / response to tumor necrosis factor / negative regulation of cell cycle / T cell homeostasis / B cell homeostasis / Pyroptosis / cell fate commitment / regulation of macroautophagy / Caspase-mediated cleavage of cytoskeletal proteins / response to X-ray / response to amino acid / response to glucose / response to UV / keratinocyte differentiation / Degradation of the extracellular matrix / striated muscle cell differentiation / intrinsic apoptotic signaling pathway / response to glucocorticoid / protein maturation / erythrocyte differentiation / response to nicotine / hippocampus development / apoptotic signaling pathway / enzyme activator activity / protein catabolic process / response to hydrogen peroxide / sensory perception of sound / protein processing / regulation of protein stability / response to wounding / neuron differentiation / response to estradiol / peptidase activity / positive regulation of neuron apoptotic process / heart development / protease binding / neuron apoptotic process / response to lipopolysaccharide / aspartic-type endopeptidase activity / learning or memory / response to hypoxia / postsynaptic density / response to xenobiotic stimulus / cysteine-type endopeptidase activity / neuronal cell body / apoptotic process / DNA damage response / protein-containing complex binding / glutamatergic synapse / proteolysis / nucleoplasm / nucleus / cytoplasm / cytosol Similarity search - Function | ||||||
| Biological species | Homo sapiens (human) | ||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.3 Å | ||||||
Authors | Fuller, J.L. / Finzel, B.C. | ||||||
| Funding support | United States, 1items
| ||||||
Citation | Journal: Arch Pharm / Year: 2022Title: Characterization of caspase-2 inhibitors based on specific sites of caspase-2-mediated proteolysis. Authors: Bresinsky, M. / Strasser, J.M. / Hubmann, A. / Vallaster, B. / McCue, W.M. / Fuller, J. / Singh, G. / Nelson, K.M. / Cuellar, M.E. / Finzel, B.C. / Ashe, K.H. / Walters, M.A. / Pockes, S. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 7uso.cif.gz | 109.7 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb7uso.ent.gz | 82.6 KB | Display | PDB format |
| PDBx/mmJSON format | 7uso.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/us/7uso ftp://data.pdbj.org/pub/pdb/validation_reports/us/7uso | HTTPS FTP |
|---|
-Related structure data
| Related structure data | ![]() 7rnaC ![]() 7rngC ![]() 7uspC ![]() 7usqC ![]() 7rnfS S: Starting model for refinement C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| Unit cell |
|
-
Components
| #1: Protein | Mass: 16639.902 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: CASP3, CPP32 / Production host: ![]() #2: Protein | Mass: 11910.604 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: CASP3, CPP32 / Production host: ![]() #3: Protein/peptide | Mass: 601.713 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: ![]() #4: Water | ChemComp-HOH / | Has ligand of interest | Y | Has protein modification | Y | |
|---|
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 2.51 Å3/Da / Density % sol: 51.06 % / Description: plate crystals grow within 48 hours |
|---|---|
| Crystal grow | Temperature: 293 K / Method: vapor diffusion, hanging drop / pH: 5.3 Details: 15% PEG 6000, 5% Glycerol, 100mM Sodium Citrate (pH 5.3), 10mM DTT, 3mM NaN3 |
-Data collection
| Diffraction | Mean temperature: 193 K / Serial crystal experiment: N |
|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: APS / Beamline: 17-ID / Wavelength: 1 Å |
| Detector | Type: DECTRIS EIGER X 9M / Detector: PIXEL / Date: Jul 17, 2021 |
| Radiation | Monochromator: Si(111) / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 1 Å / Relative weight: 1 |
| Reflection | Resolution: 2.3→36.31 Å / Num. obs: 23912 / % possible obs: 98.11 % / Redundancy: 1.9 % / Biso Wilson estimate: 35.78 Å2 / CC1/2: 0.995 / CC star: 0.999 / Rmerge(I) obs: 0.04781 / Rpim(I) all: 0.04781 / Rrim(I) all: 0.06761 / Net I/σ(I): 8.34 |
| Reflection shell | Resolution: 2.3→2.382 Å / Redundancy: 2 % / Rmerge(I) obs: 0.201 / Mean I/σ(I) obs: 3.18 / Num. unique obs: 2395 / CC1/2: 0.9 / CC star: 0.973 / Rpim(I) all: 0.201 / Rrim(I) all: 0.2843 / % possible all: 99.46 |
-
Processing
| Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: 7rnf Resolution: 2.3→36.31 Å / SU ML: 0.28 / Cross valid method: THROUGHOUT / σ(F): 1.34 / Phase error: 25.45 / Stereochemistry target values: ML
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso max: 79.61 Å2 / Biso mean: 39.2733 Å2 / Biso min: 22.1 Å2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: final / Resolution: 2.3→36.31 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell | Refine-ID: X-RAY DIFFRACTION / Rfactor Rfree error: 0 / Total num. of bins used: 9
|
Movie
Controller
About Yorodumi



Homo sapiens (human)
X-RAY DIFFRACTION
United States, 1items
Citation




PDBj


















